AKT1 and cerebral toxoplasmosis: Treatment of mice with ocular and cerebral toxoplasmosis with Saracatinib led to replacement of activated Akt for PTEN around the tachyzoites, marked reduction in parasite load and histopathology that were dependent on the autophagy protein Beclin 1.